✦ LIBER ✦

Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer

✍ Scribed by Dr Philip J. Saylor, Nancy L. Keating, Stephen J. Freedland, Matthew R. Smith

Book ID: 119931118
Publisher: Springer International Publishing AG
Year: 2011
Tongue: English
Weight: 117 KB
Volume: 71
Category: Article
ISSN: 0012-6667
DOI: 10.2165/11588930-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cardiovascular risk of gonadotropin

The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: An unresolved controversy

✍ Conteduca, Vincenza; Di Lorenzo, Giuseppe; Tartarone, Alfredo; Aieta, Michele 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 572 KB

Gonadotrophin-releasing hormone agonists

Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?

✍ Matthew R. Smith; A. James O’Malley; Nancy L. Keating 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Luteinizing hormone–releasing hormone ag

Luteinizing hormone–releasing hormone agonists in the treatment of men with prostate cancer: timing, alternatives, and the 1-year implant

✍ LEONARD S Marks 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 266 KB

677 Lower risk of cardiovascular (CV) ev

677 Lower risk of cardiovascular (CV) events and death in men receiving ADT by gonadotropin releasing hormone (GnRH) antagonist, degarelix, compared with luteinising hormone-releasing (LHRH) agonists

✍ Tombal, B.; Albertsen, P.; De La Taille, A.; Van Der Meulen, E.; Persson, B-E.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Effects of gonadotropin-releasing hormon

Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer

✍ Yoshiyuki Miyaji; Takashi Saika; Yasuo Yamamoto; Nobuyuki Kusaka; Ryoji Arata; S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 107 KB

THE GONADOTROPIN-RELEASING HORMONE ANTAG

THE GONADOTROPIN-RELEASING HORMONE ANTAGONIST ABARELIX DEPOT VERSUS LUTEINIZING HORMONE RELEASING HORMONE AGONISTS LEUPROLIDE OR GOSERELIN: INITIAL RESULTS OF ENDOCRINOLOGICAL AND BIOCHEMICAL EFFICACIES IN PATIENTS WITH PROSTATE CANCER

✍ TOMERA, KEVIN; GLEASON, DONALD; GITTELMAN, MARC; MOSELEY, WILLIAM; ZINNER, NORMA 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 76 KB